Raised $78M across disclosed rounds.[1][2][3][4][5]

Series A closed October 2021, led by Cascade Investment L.L.C..[1][2][5]

post-money valuation is not publicly disclosed.

Named investors include Cascade Investment L.L.C., Viking Global, CHANEL, Givaudan, Wittington Ventures, OLAPLEX.[1][2][5]

Jasmina Aganovic, Founder and CEO[1][5][13][4]

Jaide Jensen, Head of Biotechnology[4][13]

Joanne Hsieh, Independent Board Director[4][13]

Ginkgo Bioworks · ginkgobioworks.com · Arcaea was incubated on the Ginkgo Bioworks platform and uses its cell programming capabilities; Ginkgo is the platform provider and a related entity.[1][5]

Givaudan · givaudan.com · Givaudan is both an investor in Arcaea and a competitor in the beauty ingredients space; same buyer (beauty brands) for ingredient technologies.[1][2]

Amyris · amyris.com · Same approach: using synthetic biology and fermentation to produce cosmetic ingredients as alternatives to petrochemical-derived compounds; same buyer (beauty brands) and same workflow (ingredient development via fermentation).[1][5]

The customer proof is company-sourced only. No independent source in this ledger confirms it.[4]

Ask for one referenceable production customer.

Not a recommendation. The first thing this ledger cannot answer.

Filled in the side panel for invited readers. This card carries sourced facts only.